Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francis Fagnani

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Therapie|August 2, 2012
[The investment of pharmaceutical industry in hospital clinical research: an estimate for france in 2010]Francis Fagnani
Acta Cytologica|October 7, 2003
Performance of a new, liquid-based cervical screening technique in the clinical setting of a large French laboratoryChristine Bergeron, Francis Fagnani
American Journal of Respiratory Medicine : Drugs, Devices, and Other Interventions|January 15, 2004
Antibiotic prescribing patterns of French GPs for upper respiratory tract infections: impact of fusafungine on rates of prescription of systemic antibioticsFrancis Fagnani, Michèle German-Fattal
Therapie|October 7, 2009
[Budget impact analysis of Pradaxa thromboprophylaxis after total hip or total knee replacement]Stéphane Bouée, Paul Zufferey, Francis Fagnani
Journal of Epidemiology and Population Health|March 20, 2025
Performance diagnostique du PMSI pour identifier les candidémies à l'hôpital : une analyse des données de l'entrepôt de données de santé (EDS) du CHU de NantesCorinne Emery, Francis Fagnani, Christophe Chansou, et al.
Current Therapeutic Research, Clinical and Experimental|April 1, 2014
Therapeutic management of uncomplicated gastroesophageal reflux disease in france in 2005: Potential cost savings of omeprazole substitutionStéphane Mouly, Agnès Charlemagne, Philippe Lejeunne, et al.
Epilepsia Open|August 27, 2022
Epidemiology and disease burden of tuberous sclerosis complex in France: A population-based study based on national health insurance dataFrancis Fagnani, Caroline Laurendeau, Marie de Zelicourt, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 29, 2004
Economic evaluation of a combined DTPa, hepatitis B, polio, Hib vaccine. Potential impact of the introduction of Infanrix-Hexa in the French childhood immunisation scheduleFrancis Fagnani, Camille Le Fur, Isabelle Durand, et al.
Presse Medicale (Paris, France : 1983)|January 10, 2004
[The EPO beta injection pen in patients in maintenance dialysis or predialysis: acceptability, satisfaction and cost assessment]Corinne Emery, Francis Fagnani, Karine Perez Niddam, et al.
Presse Medicale (Paris, France : 1983)|May 27, 2008
[General practitioners' management of gastroesophageal reflux in France in 2005: a pharmacoeconomic study]Stéphane Mouly, Agnès Charlemagne, Philippe Le Jeunne, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Therapie|August 2, 2012
[The investment of pharmaceutical industry in hospital clinical research: an estimate for france in 2010]Francis Fagnani
Acta Cytologica|October 7, 2003
Performance of a new, liquid-based cervical screening technique in the clinical setting of a large French laboratoryChristine Bergeron, Francis Fagnani
American Journal of Respiratory Medicine : Drugs, Devices, and Other Interventions|January 15, 2004
Antibiotic prescribing patterns of French GPs for upper respiratory tract infections: impact of fusafungine on rates of prescription of systemic antibioticsFrancis Fagnani, Michèle German-Fattal
Therapie|October 7, 2009
[Budget impact analysis of Pradaxa thromboprophylaxis after total hip or total knee replacement]Stéphane Bouée, Paul Zufferey, Francis Fagnani
Journal of Epidemiology and Population Health|March 20, 2025
Performance diagnostique du PMSI pour identifier les candidémies à l'hôpital : une analyse des données de l'entrepôt de données de santé (EDS) du CHU de NantesCorinne Emery, Francis Fagnani, Christophe Chansou, et al.
Current Therapeutic Research, Clinical and Experimental|April 1, 2014
Therapeutic management of uncomplicated gastroesophageal reflux disease in france in 2005: Potential cost savings of omeprazole substitutionStéphane Mouly, Agnès Charlemagne, Philippe Lejeunne, et al.
Epilepsia Open|August 27, 2022
Epidemiology and disease burden of tuberous sclerosis complex in France: A population-based study based on national health insurance dataFrancis Fagnani, Caroline Laurendeau, Marie de Zelicourt, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 29, 2004
Economic evaluation of a combined DTPa, hepatitis B, polio, Hib vaccine. Potential impact of the introduction of Infanrix-Hexa in the French childhood immunisation scheduleFrancis Fagnani, Camille Le Fur, Isabelle Durand, et al.
Presse Medicale (Paris, France : 1983)|January 10, 2004
[The EPO beta injection pen in patients in maintenance dialysis or predialysis: acceptability, satisfaction and cost assessment]Corinne Emery, Francis Fagnani, Karine Perez Niddam, et al.
Presse Medicale (Paris, France : 1983)|May 27, 2008
[General practitioners' management of gastroesophageal reflux in France in 2005: a pharmacoeconomic study]Stéphane Mouly, Agnès Charlemagne, Philippe Le Jeunne, et al.
Pageof 5